{
    "clinical_study": {
        "@rank": "132628", 
        "arm_group": [
            {
                "arm_group_label": "Reference Glucose", 
                "arm_group_type": "Other", 
                "description": "Glucose standard"
            }, 
            {
                "arm_group_label": "Test Food 1", 
                "arm_group_type": "Experimental", 
                "description": "Cereal"
            }, 
            {
                "arm_group_label": "Test Food 2", 
                "arm_group_type": "Experimental", 
                "description": "Biscuit"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, postprandial glucose and insulin responses of different foods will be\n      measured in individuals with varying body weight."
        }, 
        "brief_title": "Glucose and Insulin Responses to Test Foods", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Glucose Response", 
            "Insulin Response"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants will be non-smoking males or non-pregnant females aged 20-45y, with\n             normal glycemia and in good health.  A total of 12 participants will be included,\n             where approximately half will be male & half female, and half normal weight (BMI >\n             19.0 and < 25.0) and half overweight but not obese (BMI > 25.0 and < 30).  Thus, no\n             fewer than 5 male, 5 female, 5 normal weight and 5 overweight but not obese subjects\n             will be included. Additional inclusion criteria will include:\n\n          -  Absence of diabetes, impaired glucose tolerance and impaired fasting glucose, defined\n             as having a fasting plasma glucose < 5.6 mmol/L (100 mg/dL) AND  plasma glucose\n             levels < 7.8 mmol/L (140 mg/dL) 2h after consumption of a 50 g glucose drink (OGTT\n             will be administered during the screening visit)\n\n          -  Systolic blood pressure 100-150 mmHg inclusive\n\n          -  Diastolic blood pressure 60-90 mmHg inclusive\n\n          -  Resting heart rate 50-90 beats/min inclusive after 3 minute rest\n\n          -  Able to refrain from eating legumes and drinking alcohol the day before each test\n             session\n\n          -  Fasting triglycerides < 2.0 mmol/L (178 mg/dL)\n\n          -  Fasting HDL cholesterol > 0.9 mmol/L (35 mg/dL) for males and > 1.1mmol/L (42 mg/dL)\n             for females\n\n          -  Fasting LDL cholesterol < 5.0 mmol/L (193 mg/dL)\n\n          -  AST and ALT < 120% of upper limit of normal (ULN)\n\n          -  hsCRP < 10 mg/L\n\n          -  Urea and creatinine < 150% ULN\n\n        Exclusion Criteria:\n\n          -  failure to meet any one of the inclusion criteria\n\n          -  age less than 18 or over 45 years\n\n          -  known history or AIDS, hepatitis, diabetes or a heart condition\n\n          -  participants using medications or with any condition which might, in the opinion of\n             Dr. Wolever, the president of GI Testing, either: 1) make participation dangerous to\n             the subject or to others, or 2) affect the results\n\n          -  participants who cannot or will not comply with the experimental procedures or do not\n             follow GI Labs safety guidelines.\n\n          -  Food allergies of any kind\n\n          -  General anaesthesia in the month prior to inclusion.\n\n          -  Smokers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01671878", 
            "org_study_id": "GIl1244"
        }, 
        "intervention": [
            {
                "arm_group_label": "Reference Glucose", 
                "intervention_name": "Reference Glucose", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Test Food 1", 
                "intervention_name": "Test Food 1 (Cereal)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Test Food 2", 
                "intervention_name": "Test Food 2 (Biscuit)", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5C 2N8"
                }, 
                "name": "Glycemic Index Laboratories"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "Characterization of the Postprandial Glucose and Insulin Responses to Test Foods in Lean and Overweight Subjects", 
        "overall_official": {
            "affiliation": "Glycemic Index Laboratories, Inc", 
            "last_name": "Thomas Wolever, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Postprandial Glucose Response", 
            "safety_issue": "No", 
            "time_frame": "3 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01671878"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Postprandial Insulin Response", 
            "safety_issue": "No", 
            "time_frame": "3 hours"
        }, 
        "source": "Mondel\u0113z International, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Glycemic Index Laboratories, Inc", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Mondel\u0113z International, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}